Adapting To The Evolving Era Of Oncology: Implications And Strategies For Research Institutions

The field of oncology is advancing rapidly with the rise of biomarker-directed therapies, transforming treatment approaches and offering more personalized patient care. As research institutions adapt to this shift, maintaining ethical standards, regulatory compliance, and sound protocol design is essential to handle the complexities of genomic data in cancer research. This discussion, featuring Vanessa Hill, Director of Research Compliance at Advarra, and Michelle Green, Genomics Program Manager at LabCorp, delves into current ethical and regulatory challenges in oncology research. Explore cutting-edge trends and strategies that can help institutions stay at the forefront of oncology's evolving landscape.